Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10599-10605
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10599
Figure 1
Figure 1 Kinetics of hepatitis C virus based on different viral genotypes. Mean hepatitis C virus (HCV)-RNA levels (log10IU/mL) at different time points (days 0, 2, 7, 14, 21, 28). During the first 4 wk of pegylated interferon and ribavirin therapy according to HCV genotypes. HCV-1: HCV genotype 1; HCV-3: HCV genotype 3; HCV-6: HCV genotype 6.
Figure 2
Figure 2 Kinetics of hepatitis C virus based on the single nucleotide polymorphism rs12979860 alleles. Mean hepatitis C virus (HCV)-RNA levels (log10IU/mL) at different time points (days 0, 2, 7, 14, 21, 28). During the first 4 wk of pegylated interferon and ribavirin treatment according to rs12979860 genotypes. A: HCV genotype 1; B: HCV genotype 3; C: HCV genotype 6.
Figure 3
Figure 3 Changes in serum hepatitis C virus RNA concentrations according to rs12979860 genotypes. A: The first phase (days 0-2); B: The second phase (days 7-28) hepatitis C virus (HCV)-1: HCV genotype 1; HCV-3: HCV genotype 3; HCV-6: HCV genotype 6; Data described as mean ± SD.